Theorem Clinical Research has signed a deal with Biomedical Systems to expand its testing services, enlisting a partner with expertise in diagnostics.
|Theorem CEO John Potthoff|
Headquartered in St. Louis, Biomedical Systems specializes in providing sponsors and CROs with a broad range of diagnostic tests used in clinical trials. Through the partnership, Theorem and its clients get access to the company's fleet of testing services, while Biomedical Systems gains access to new markets through the CRO's expansive reach.
"Biomedical Systems is one of the true pioneers in our industry, supervising breakthrough research innovations in centralized cardiac safety, pulmonary function, imaging, scientific affairs and electronic clinical outcome assessment (eCOA)," Theorem CEO John Potthoff said in a statement. "The company's broad range of capabilities and global scale are a complement to Theorem studies being conducted around the world."
The agreement follows a slew of partnerships for the expansion-minded Theorem. Over the past 18 months, the Pennsylvania CRO has signed a deal with India's Excel Life Sciences to broaden its footprint in that country, joined Decision Driver Analytics to expand its post-market efforts, teamed up with Charles River Laboratories ($CRL) on preclinical research and reached out to Emergo to better capitalize on med tech.
- read the statement